Acute Myeloid Leukemia AML Cytogenetics Panel Test
Comprehensive Genetic Analysis for AML Diagnosis and Treatment
The Acute Myeloid Leukemia AML Cytogenetics Panel represents a cutting-edge diagnostic approach that combines multiple genetic testing methodologies to provide comprehensive insights into the chromosomal and molecular characteristics of acute myeloid leukemia. This advanced panel is essential for modern hematologic oncology practice, offering critical information that directly impacts treatment decisions and patient outcomes.
What This Test Measures and Detects
Our comprehensive cytogenetics panel utilizes sophisticated laboratory techniques to identify specific genetic abnormalities that define AML subtypes and influence disease behavior:
- Chromosomal Translocations: Detection of t(8;21) involving ETO/AML1 genes, t(15;17) involving PML/RARA genes, and t(16;16) or inv(16) involving CBFB gene
- MLL Gene Rearrangements: Identification of t(variable;11q23) abnormalities affecting the MLL gene
- Comprehensive Chromosome Analysis: Full karyotyping to identify numerical and structural chromosomal abnormalities
- Hematological Malignancy Markers: Broad assessment of genetic features specific to blood cancers
Who Should Consider This Test
This comprehensive genetic panel is recommended for individuals presenting with:
- Newly diagnosed acute myeloid leukemia requiring complete genetic characterization
- Unexplained cytopenias (low blood counts) with suspicious bone marrow findings
- Patients with AML who have failed initial treatment or show disease progression
- Individuals requiring risk stratification for treatment intensity decisions
- Patients being evaluated for targeted therapy options based on genetic markers
- Cases where precise AML subclassification is necessary for prognosis assessment
Clinical Benefits of AML Cytogenetics Testing
Undergoing comprehensive cytogenetic analysis provides multiple clinical advantages:
- Accurate Diagnosis: Precise identification of AML subtypes based on genetic abnormalities
- Risk Stratification: Determination of favorable, intermediate, or poor-risk genetic profiles
- Treatment Guidance: Information crucial for selecting appropriate chemotherapy regimens
- Targeted Therapy Eligibility: Identification of patients who may benefit from specific molecular targeted agents
- Prognostic Information: Insights into likely disease course and treatment response
- Monitoring Tool: Baseline genetic profile for future disease monitoring
Understanding Your Test Results
Your cytogenetics panel results will provide detailed information about the genetic landscape of your AML:
- Normal Karyotype: No chromosomal abnormalities detected, typically associated with intermediate risk
- Favorable Abnormalities: Presence of t(8;21), inv(16), or t(15;17) indicating better prognosis
- Unfavorable Markers: Complex karyotypes or specific high-risk abnormalities requiring intensive treatment
- MLL Rearrangements: Specific genetic changes that may influence treatment approach
- Risk Category Assignment: Classification into favorable, intermediate, or adverse risk groups based on genetic findings
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Acute Myeloid Leukemia AML Cytogenetics Panel Test | 576 USD | 800 USD |
Nationwide Testing Availability
We provide comprehensive AML cytogenetics testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.
Sample Requirements and Processing
For accurate testing, we require:
- 8 mL (6 mL minimum) whole blood collected in 2 Green Top Sodium Heparin tubes
- 4 mL (2 mL minimum) bone marrow aspirate in 1 Green Top Sodium Heparin tube
- Proper temperature maintenance during transport (18-22°C)
- Completed Chromosome and FISH analysis Requisition form (Form 17)
Turnaround Time: Samples received daily by 4 pm; Reports delivered within 4 working days
Take Control of Your AML Diagnosis Today
Comprehensive genetic analysis is essential for optimal AML management. Our advanced cytogenetics panel provides the critical information needed for accurate diagnosis, prognosis assessment, and personalized treatment planning. Don’t leave your treatment decisions to chance – get the complete genetic picture with our specialized testing.
Ready to schedule your test? Call or WhatsApp us today at +1(267) 388-9828 to book your Acute Myeloid Leukemia AML Cytogenetics Panel and take the first step toward personalized cancer care.